诚意药业
(603811)
| 流通市值：29.10亿 | | | 总市值：29.10亿 |
| 流通股本：3.27亿 | | | 总股本：3.27亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 520,542,330.59 | 355,789,053.38 | 153,058,271.42 | 671,626,943.73 |
| 营业收入 | 520,542,330.59 | 355,789,053.38 | 153,058,271.42 | 671,626,943.73 |
| 二、营业总成本 | 437,021,620.72 | 291,534,398.15 | 127,302,359.23 | 552,305,485.15 |
| 营业成本 | 161,290,949.46 | 107,760,670.41 | 45,231,210.48 | 240,597,520.13 |
| 税金及附加 | 10,863,071.94 | 6,774,261.69 | 2,957,578.38 | 9,190,691.32 |
| 销售费用 | 132,692,285.97 | 94,108,676.09 | 39,746,999.05 | 152,572,844.99 |
| 管理费用 | 88,823,175.31 | 55,927,218.49 | 26,043,599.42 | 96,285,150.58 |
| 研发费用 | 37,135,931.42 | 22,986,655.44 | 11,781,100.15 | 47,144,451.73 |
| 财务费用 | 6,216,206.62 | 3,976,916.03 | 1,541,871.75 | 6,514,826.4 |
| 其中:利息费用 | 8,799,172.07 | 6,659,716.87 | 3,385,847.18 | 15,260,927.36 |
| 其中:利息收入 | 2,960,701.09 | 2,775,272.91 | 1,886,906.05 | 8,984,546.52 |
| 加:投资收益 | 30,981,776.88 | 19,862,597.26 | 10,381,569.14 | 58,136,527.47 |
| 资产处置收益 | 8,359,205.6 | - | - | -354.08 |
| 资产减值损失(新) | -2,496,163.19 | -3,638,319.65 | -1,625,240.36 | -13,323,605.17 |
| 信用减值损失(新) | 1,527,916.8 | 461,813.87 | 495,927.71 | -1,173,527.09 |
| 其他收益 | 8,310,319.95 | 6,147,826.87 | 2,500,903.79 | 10,948,741.41 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 130,203,765.91 | 87,088,573.58 | 37,509,072.47 | 173,909,241.12 |
| 加:营业外收入 | 770,885.81 | 756,955.96 | 325,569.95 | 621,403.37 |
| 减:营业外支出 | 684,770.3 | 496,459.25 | 179,485.06 | 468,462.11 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 130,289,881.42 | 87,349,070.29 | 37,655,157.36 | 174,062,182.38 |
| 减:所得税费用 | 13,280,729.6 | 10,833,220.78 | 4,925,117.54 | 12,012,222.65 |
| 六、净利润 | 117,009,151.82 | 76,515,849.51 | 32,730,039.82 | 162,049,959.73 |
| 持续经营净利润 | 117,009,151.82 | 76,515,849.51 | 32,730,039.82 | 162,049,959.73 |
| 归属于母公司股东的净利润 | 117,073,573.87 | 76,465,500.27 | 32,684,974.03 | 162,896,651.5 |
| 少数股东损益 | -64,422.05 | 50,349.24 | 45,065.79 | -846,691.77 |
| (一)基本每股收益 | 0.36 | 0.23 | 0.1 | 0.5 |
| (二)稀释每股收益 | 0.36 | 0.23 | 0.1 | 0.5 |
| 八、其他综合收益 | 29,129.17 | 21,298.43 | 13,923.53 | -22,670.53 |
| 归属于母公司股东的其他综合收益 | 26,216.25 | 19,168.59 | 12,531.18 | -20,403.48 |
| 九、综合收益总额 | 117,038,280.99 | 76,537,147.94 | 32,743,963.35 | 162,027,289.2 |
| 归属于母公司股东的综合收益总额 | 117,099,790.12 | 76,484,668.86 | 32,697,505.21 | 162,876,248.02 |
| 归属于少数股东的综合收益总额 | -61,509.13 | 52,479.08 | 46,458.14 | -848,958.82 |
| 公告日期 | 2024-10-29 | 2024-08-21 | 2024-04-26 | 2024-04-26 |
| 审计意见(境内) | | | | 标准无保留意见 |